Capital Analysts LLC’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9
Closed -$224 – 1728
2026
Q2
$224 Buy
+9
New +$211 ﹤0.01% 1550
2015
Q1
– Sell
-46
Closed -$2.09K – 384
2014
Q4
$2.09K Buy
+46
New +$1.81K ﹤0.01% 384

Other funds holding AVNS

Capital Analysts LLC's AVNS Position: Q3 2026 in Review

Capital Analysts LLC sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 9 shares — an estimated $224 sold.

Capital Analysts LLC first reported a position in AVNS in Q4 2014 and held it in 2 quarters. The position peaked at $2.09K in Q4 2014. 4 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Capital Analysts LLC reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Capital Analysts LLC sold 9 Avanos Medical shares in Q3 2026, an estimated $224.
  • Capital Analysts LLC first reported a position in Avanos Medical in Q4 2014 and held it in 2 quarters.
  • Capital Analysts LLC's Avanos Medical position peaked at $2.09K in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.